Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Samantha MaWhinney

Concepts (515)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
91
2026
3148
4.700
 Why?
Anti-HIV Agents
41
2026
890
4.040
 Why?
Adenine
18
2026
337
2.750
 Why?
Tenofovir
20
2026
295
2.590
 Why?
Dried Blood Spot Testing
10
2026
126
2.200
 Why?
Organophosphates
15
2026
179
1.930
 Why?
Emtricitabine
16
2025
205
1.920
 Why?
Acquired Immunodeficiency Syndrome
10
2023
235
1.510
 Why?
HIV-1
31
2021
897
1.420
 Why?
Patient Dropouts
3
2025
65
1.070
 Why?
Pre-Exposure Prophylaxis
8
2025
247
0.820
 Why?
Viral Load
21
2026
528
0.820
 Why?
Medication Adherence
12
2025
540
0.810
 Why?
Drug Monitoring
7
2024
396
0.680
 Why?
Frailty
4
2026
200
0.650
 Why?
High-Intensity Interval Training
3
2026
45
0.630
 Why?
Viremia
7
2026
159
0.610
 Why?
Middle Aged
72
2026
35971
0.560
 Why?
Aging
10
2026
1938
0.540
 Why?
Directly Observed Therapy
1
2017
15
0.530
 Why?
Adult
65
2026
40489
0.500
 Why?
Humans
133
2026
144667
0.490
 Why?
Male
85
2026
72431
0.470
 Why?
Anti-Retroviral Agents
5
2019
250
0.460
 Why?
Pulmonary Disease, Chronic Obstructive
1
2023
919
0.460
 Why?
Leukocytes, Mononuclear
9
2021
572
0.450
 Why?
Female
83
2026
78304
0.430
 Why?
Exercise
7
2026
2183
0.420
 Why?
Exercise Therapy
4
2026
475
0.410
 Why?
Zidovudine
3
2012
77
0.410
 Why?
Lamivudine
3
2012
65
0.410
 Why?
Body Composition
5
2026
689
0.400
 Why?
Unsafe Sex
2
2012
61
0.400
 Why?
Cytochrome P-450 CYP3A
2
2012
93
0.370
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
2
2025
19
0.370
 Why?
CD8-Positive T-Lymphocytes
9
2018
915
0.350
 Why?
Sofosbuvir
4
2022
61
0.350
 Why?
T-Lymphocytes, Cytotoxic
6
2014
177
0.350
 Why?
Oligopeptides
2
2012
266
0.340
 Why?
Cohort Studies
10
2026
5957
0.340
 Why?
Atazanavir Sulfate
4
2016
42
0.320
 Why?
Models, Statistical
5
2022
677
0.320
 Why?
Sustained Virologic Response
3
2019
46
0.320
 Why?
HIV Integrase Inhibitors
2
2024
78
0.310
 Why?
Prospective Studies
23
2022
7994
0.310
 Why?
Receptors, CCR5
6
2013
60
0.310
 Why?
Sarcopenia
2
2026
91
0.300
 Why?
Dideoxynucleotides
2
2012
16
0.300
 Why?
Mobile Applications
2
2022
197
0.300
 Why?
Cytidine Triphosphate
2
2012
19
0.300
 Why?
CD4-Positive T-Lymphocytes
9
2016
1129
0.300
 Why?
Phosphorous Acids
2
2019
15
0.300
 Why?
Levonorgestrel
2
2012
34
0.290
 Why?
Emigrants and Immigrants
1
2012
158
0.290
 Why?
Pyridines
2
2012
603
0.280
 Why?
Antiviral Agents
3
2019
765
0.280
 Why?
Sarcoma, Kaposi
3
2022
83
0.270
 Why?
Antiretroviral Therapy, Highly Active
8
2019
278
0.270
 Why?
Aged
29
2026
25955
0.270
 Why?
Longitudinal Studies
7
2025
2942
0.270
 Why?
Quality of Life
7
2023
3183
0.250
 Why?
Lymphocyte Activation
10
2018
1124
0.250
 Why?
Gonadal Steroid Hormones
1
2008
143
0.250
 Why?
Prion Diseases
1
2006
15
0.250
 Why?
Deoxyadenine Nucleotides
2
2016
15
0.250
 Why?
Deoxycytosine Nucleotides
2
2016
13
0.250
 Why?
Creutzfeldt-Jakob Syndrome
1
2006
18
0.250
 Why?
Wasting Disease, Chronic
1
2006
26
0.240
 Why?
Data Interpretation, Statistical
2
2025
368
0.240
 Why?
Lymph Nodes
6
2017
501
0.230
 Why?
Coronary Artery Bypass
8
2004
267
0.230
 Why?
Inflammation
5
2021
2870
0.230
 Why?
Gene Expression
2
2014
1476
0.230
 Why?
Young Adult
17
2025
14122
0.220
 Why?
Simian Immunodeficiency Virus
2
2016
93
0.220
 Why?
Bias
2
2025
197
0.220
 Why?
Simian Acquired Immunodeficiency Syndrome
2
2016
92
0.220
 Why?
CD4 Lymphocyte Count
11
2020
277
0.220
 Why?
Contraceptives, Postcoital
1
2004
2
0.210
 Why?
HIV
4
2019
248
0.210
 Why?
Cross-Over Studies
4
2020
605
0.200
 Why?
Computer Simulation
4
2025
1021
0.200
 Why?
Population Surveillance
3
2002
484
0.200
 Why?
Cytokines
3
2009
2045
0.200
 Why?
Physical Fitness
2
2015
207
0.200
 Why?
Advance Care Planning
2
2021
243
0.190
 Why?
Lipopolysaccharide Receptors
2
2021
87
0.190
 Why?
HIV Integrase
1
2024
74
0.190
 Why?
Fluorenes
2
2020
46
0.190
 Why?
HIV Seropositivity
3
2012
119
0.180
 Why?
Drug Resistance, Viral
2
2019
123
0.180
 Why?
Cell Phone
1
2022
82
0.180
 Why?
Telerehabilitation
1
2022
43
0.180
 Why?
Lymphoid Tissue
3
2008
78
0.170
 Why?
Hepatitis C
2
2022
254
0.170
 Why?
RNA, Viral
9
2014
689
0.170
 Why?
Benzimidazoles
2
2020
187
0.170
 Why?
Hair
2
2018
86
0.170
 Why?
Protease Inhibitors
2
2020
101
0.170
 Why?
Alanine
4
2024
170
0.170
 Why?
Fees and Charges
1
2000
11
0.160
 Why?
Ritonavir
2
2012
75
0.160
 Why?
Polyphosphates
4
2022
45
0.160
 Why?
Hyperlipidemias
1
2021
120
0.160
 Why?
Interleukin-10
2
2021
310
0.160
 Why?
Mitochondria, Muscle
1
2021
120
0.160
 Why?
Research Design
2
2025
1129
0.150
 Why?
Advance Directives
1
2021
88
0.150
 Why?
Costs and Cost Analysis
1
2000
221
0.150
 Why?
ADP-ribosyl Cyclase 1
4
2013
42
0.150
 Why?
Thymine Nucleotides
2
2016
19
0.150
 Why?
Biomarkers
7
2021
4261
0.150
 Why?
Hepatitis C, Chronic
2
2019
152
0.140
 Why?
Cytomegalovirus Infections
2
2015
205
0.140
 Why?
Myocardial Ischemia
1
2000
285
0.140
 Why?
Blood Chemical Analysis
4
2019
109
0.140
 Why?
Simeprevir
1
2018
5
0.140
 Why?
Colorado
7
2022
4558
0.140
 Why?
Raltegravir Potassium
2
2015
18
0.130
 Why?
Heterocyclic Compounds, 3-Ring
1
2018
44
0.130
 Why?
Virus Replication
5
2017
525
0.130
 Why?
Epitopes, T-Lymphocyte
4
2008
175
0.130
 Why?
Transgender Persons
1
2021
207
0.130
 Why?
Viral Tropism
1
2017
36
0.130
 Why?
Pharmacogenetics
2
2016
172
0.130
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2021
438
0.130
 Why?
AIDS-Related Opportunistic Infections
3
2007
130
0.120
 Why?
T-Lymphocytes, Helper-Inducer
1
2017
130
0.120
 Why?
Pyrophosphatases
1
2016
26
0.120
 Why?
Deoxyguanine Nucleotides
1
2016
12
0.120
 Why?
Lung
3
2026
4089
0.120
 Why?
Length of Stay
4
2000
1339
0.120
 Why?
Genitalia
1
2016
34
0.120
 Why?
Motor Activity
4
2015
723
0.120
 Why?
Sleep Wake Disorders
1
2020
308
0.120
 Why?
Time Factors
9
2026
7140
0.120
 Why?
Germinal Center
1
2016
67
0.120
 Why?
Academic Medical Centers
1
2019
545
0.120
 Why?
Ribavirin
1
2016
80
0.120
 Why?
Vaccines, DNA
2
2008
32
0.120
 Why?
HIV Protease Inhibitors
2
2016
69
0.120
 Why?
AIDS Vaccines
2
2008
53
0.120
 Why?
Purines
1
2016
187
0.110
 Why?
Muscle Strength
1
2018
330
0.110
 Why?
Disease Transmission, Infectious
2
2018
68
0.110
 Why?
T-Lymphocyte Subsets
4
2015
412
0.110
 Why?
Risk Factors
11
2021
10796
0.110
 Why?
Biometry
2
2011
66
0.110
 Why?
HLA-DR Antigens
3
2012
220
0.110
 Why?
Case-Control Studies
7
2016
3603
0.110
 Why?
Genitalia, Female
1
2015
42
0.110
 Why?
Rectum
1
2016
183
0.110
 Why?
Antibodies, Viral
3
2015
672
0.110
 Why?
Linear Models
4
2020
845
0.110
 Why?
Organophosphonates
1
2015
97
0.110
 Why?
T-Lymphocytes, Regulatory
1
2017
394
0.110
 Why?
Probability
2
2011
309
0.110
 Why?
Calcifediol
1
2014
31
0.100
 Why?
Mental Health Services
1
2019
472
0.100
 Why?
Calcitriol
1
2014
57
0.100
 Why?
Immunoglobulin Variable Region
1
2014
80
0.100
 Why?
Deoxycytidine
1
2015
222
0.100
 Why?
Antimicrobial Cationic Peptides
1
2014
81
0.100
 Why?
Membrane Glycoproteins
3
2013
496
0.100
 Why?
Disease Progression
4
2015
2847
0.100
 Why?
Sexual and Gender Minorities
1
2017
254
0.100
 Why?
Multivariate Analysis
8
2007
1537
0.100
 Why?
Patient Compliance
1
2017
587
0.100
 Why?
Resistance Training
2
2026
185
0.100
 Why?
Decision Making
1
2021
973
0.100
 Why?
Telemedicine
1
2022
957
0.100
 Why?
Chromatography, Liquid
3
2019
444
0.100
 Why?
Microbiota
1
2021
782
0.100
 Why?
Immunoglobulin G
2
2015
886
0.100
 Why?
Adolescent
14
2020
22409
0.090
 Why?
Gastrointestinal Microbiome
1
2021
771
0.090
 Why?
Hand Strength
2
2026
144
0.090
 Why?
Immunologic Factors
1
2015
259
0.090
 Why?
Infectious Disease Transmission, Vertical
1
1994
193
0.090
 Why?
Spleen
1
2014
510
0.090
 Why?
Hepatitis A Vaccines
1
2012
19
0.090
 Why?
Hepatitis A
1
2012
25
0.090
 Why?
Benzoxazines
1
2012
31
0.090
 Why?
Dendritic Cells
2
2008
498
0.090
 Why?
Numerical Analysis, Computer-Assisted
2
2002
18
0.090
 Why?
Diabetes Mellitus
1
2020
1076
0.090
 Why?
Cervix Uteri
1
2012
50
0.090
 Why?
Cell Movement
3
2016
959
0.090
 Why?
Emergency Service, Hospital
1
2004
2325
0.090
 Why?
Tandem Mass Spectrometry
3
2019
565
0.090
 Why?
Marijuana Smoking
1
2015
249
0.090
 Why?
Contraceptive Agents
1
2012
65
0.090
 Why?
Benchmarking
2
2024
189
0.090
 Why?
Haplotypes
2
2012
495
0.090
 Why?
Polymorphism, Genetic
2
2016
613
0.090
 Why?
B-Lymphocytes
1
2016
875
0.080
 Why?
Muscle, Skeletal
1
2021
1788
0.080
 Why?
CD4 Antigens
1
2011
137
0.080
 Why?
Contraceptive Agents, Female
1
2012
80
0.080
 Why?
Sex Factors
5
2018
2104
0.080
 Why?
HIV Seronegativity
1
2010
29
0.080
 Why?
Antacids
1
2010
16
0.080
 Why?
Fatigue
2
2026
363
0.080
 Why?
Pyrrolidinones
1
2010
29
0.080
 Why?
Hypertension, Pulmonary
1
2022
1948
0.080
 Why?
Mental Disorders
1
2019
1154
0.080
 Why?
Retrospective Studies
9
2021
17149
0.080
 Why?
Osteoporosis
1
2013
236
0.080
 Why?
Frail Elderly
2
2026
135
0.080
 Why?
Treatment Outcome
11
2026
11735
0.080
 Why?
Herpesvirus 8, Human
2
2000
67
0.080
 Why?
Phenotype
5
2026
3147
0.080
 Why?
Diphosphates
2
2021
20
0.080
 Why?
Postmenopause
1
2012
390
0.080
 Why?
Accidental Falls
1
2012
221
0.080
 Why?
Predictive Value of Tests
4
2019
2117
0.070
 Why?
Cross-Sectional Studies
8
2019
5870
0.070
 Why?
Pyridones
2
2024
201
0.070
 Why?
Cytomegalovirus
2
2015
168
0.070
 Why?
Drug Interactions
3
2019
401
0.070
 Why?
Zimbabwe
3
2022
76
0.070
 Why?
Complementarity Determining Regions
2
2014
53
0.070
 Why?
Age Factors
4
2026
3329
0.070
 Why?
Molecular Sequence Data
3
2009
2909
0.070
 Why?
Polymorphism, Single Nucleotide
2
2016
2137
0.070
 Why?
Cytotoxicity Tests, Immunologic
3
2003
37
0.070
 Why?
Hepacivirus
2
2022
243
0.070
 Why?
Demography
2
2022
287
0.070
 Why?
Sequence Analysis, DNA
2
2009
828
0.070
 Why?
Lung Diseases
1
2015
781
0.070
 Why?
Mutation
2
2014
4081
0.070
 Why?
Healthy Volunteers
2
2018
215
0.070
 Why?
Plasma
1
2009
223
0.070
 Why?
Absorptiometry, Photon
2
2026
276
0.060
 Why?
Interleukin-12
2
1998
117
0.060
 Why?
Hospitals, Veterans
3
2004
258
0.060
 Why?
Managed Care Programs
1
2007
140
0.060
 Why?
Adipocytes
1
2008
223
0.060
 Why?
Deer
1
2006
34
0.060
 Why?
Interferon-gamma
3
2008
781
0.060
 Why?
Physicians, Family
1
2007
173
0.060
 Why?
Comorbidity
3
2019
1652
0.060
 Why?
Therapeutic Equivalency
2
2018
31
0.060
 Why?
Self Report
2
2021
869
0.060
 Why?
Preventive Health Services
1
2007
154
0.060
 Why?
Interleukin-6
2
2021
770
0.060
 Why?
Kenya
1
2025
127
0.060
 Why?
Macaca mulatta
2
2016
186
0.060
 Why?
Flow Cytometry
4
2015
1154
0.050
 Why?
Forced Expiratory Volume
1
2026
448
0.050
 Why?
T-Lymphocytes
3
2005
1984
0.050
 Why?
Immunoenzyme Techniques
1
2005
197
0.050
 Why?
Incidence
4
2012
2892
0.050
 Why?
Area Under Curve
2
2018
329
0.050
 Why?
Licensure, Pharmacy
1
2004
1
0.050
 Why?
Northern Ireland
1
2004
12
0.050
 Why?
Geriatric Assessment
1
2026
233
0.050
 Why?
Immunologic Memory
2
2009
366
0.050
 Why?
Respiratory Function Tests
1
2026
541
0.050
 Why?
New York City
2
1994
89
0.050
 Why?
Odds Ratio
3
2014
1076
0.050
 Why?
Fluorescent Antibody Technique
3
2015
364
0.050
 Why?
Programmed Cell Death 1 Receptor
2
2016
264
0.050
 Why?
Survival Analysis
3
2015
1370
0.050
 Why?
HIV Antibodies
2
2014
61
0.050
 Why?
Pilot Projects
3
2022
1886
0.050
 Why?
Conserved Sequence
1
2003
247
0.050
 Why?
Hospitalization
3
2022
2446
0.050
 Why?
Ki-67 Antigen
2
2017
117
0.050
 Why?
Integrases
1
2024
122
0.050
 Why?
Patient Satisfaction
1
2007
707
0.050
 Why?
Surveys and Questionnaires
2
2014
6041
0.050
 Why?
Reverse Transcriptase Inhibitors
1
2002
87
0.050
 Why?
Tablets
1
2022
41
0.050
 Why?
Cells, Cultured
4
2017
4110
0.050
 Why?
Creatinine
3
2018
509
0.050
 Why?
Likelihood Functions
3
2001
139
0.050
 Why?
Quality of Health Care
1
2007
692
0.050
 Why?
Triazoles
1
2024
184
0.050
 Why?
Drug Therapy, Combination
2
2018
1044
0.040
 Why?
Bayes Theorem
2
2020
426
0.040
 Why?
Models, Biological
2
2016
1811
0.040
 Why?
Habits
1
2022
52
0.040
 Why?
Drug Prescriptions
1
2004
283
0.040
 Why?
Voltage-Dependent Anion Channel 1
1
2021
15
0.040
 Why?
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
1
2021
39
0.040
 Why?
Angina Pectoris
1
2001
75
0.040
 Why?
Citrate (si)-Synthase
1
2021
53
0.040
 Why?
Sex Characteristics
1
2007
776
0.040
 Why?
Antigens, Viral
3
2014
182
0.040
 Why?
Receptors, Tumor Necrosis Factor, Type II
1
2021
41
0.040
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2021
80
0.040
 Why?
Mental Health
2
2019
792
0.040
 Why?
Diagnosis-Related Groups
1
2000
35
0.040
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
331
0.040
 Why?
Hemarthrosis
1
2000
22
0.040
 Why?
Heart Valves
1
2000
43
0.040
 Why?
HIV Antigens
2
2015
17
0.040
 Why?
Death
1
2021
131
0.040
 Why?
Weight Gain
1
2024
557
0.040
 Why?
Actigraphy
1
2020
147
0.040
 Why?
Communicable Diseases
1
2002
166
0.040
 Why?
Weight Loss
2
2020
839
0.040
 Why?
Virus Diseases
1
2002
218
0.040
 Why?
Superoxide Dismutase
1
2021
303
0.040
 Why?
Immunophenotyping
3
2007
318
0.040
 Why?
Amino Acid Motifs
2
2014
220
0.040
 Why?
Sickness Impact Profile
1
1999
62
0.040
 Why?
Regression Analysis
2
2007
998
0.040
 Why?
Drug Combinations
1
2020
393
0.040
 Why?
Capsules
1
2018
42
0.040
 Why?
Survivors
1
2022
519
0.030
 Why?
Herpesviridae Infections
1
1999
149
0.030
 Why?
Cytotoxicity, Immunologic
3
2007
221
0.030
 Why?
Chemoprevention
1
2018
91
0.030
 Why?
Chemistry Techniques, Analytical
1
2018
20
0.030
 Why?
Nanomedicine
1
2018
46
0.030
 Why?
Uganda
1
2018
92
0.030
 Why?
Renal Insufficiency
1
2000
172
0.030
 Why?
Metabolic Clearance Rate
1
2018
115
0.030
 Why?
Oxazines
1
2018
37
0.030
 Why?
Hemophilia A
1
2000
147
0.030
 Why?
Drug Compounding
1
2018
107
0.030
 Why?
Histoplasmosis
1
1997
15
0.030
 Why?
Feasibility Studies
1
2022
1103
0.030
 Why?
Heart Diseases
2
2000
341
0.030
 Why?
Fibrin Fibrinogen Degradation Products
1
2018
92
0.030
 Why?
Fluconazole
1
1997
23
0.030
 Why?
Severity of Illness Index
3
2000
2922
0.030
 Why?
Cardiology Service, Hospital
1
1997
29
0.030
 Why?
Palatine Tonsil
1
2017
55
0.030
 Why?
Adaptation, Physiological
1
2021
567
0.030
 Why?
Cause of Death
1
2019
464
0.030
 Why?
Inosine Triphosphate
1
2016
2
0.030
 Why?
Early Detection of Cancer
1
2022
472
0.030
 Why?
Genotype
3
2012
1847
0.030
 Why?
Anemia, Hemolytic
1
2016
16
0.030
 Why?
Aged, 80 and over
2
2021
8284
0.030
 Why?
Perforin
1
2016
21
0.030
 Why?
Clinical Studies as Topic
1
2016
12
0.030
 Why?
Internet
1
2002
698
0.030
 Why?
Models, Theoretical
1
2000
578
0.030
 Why?
Guanosine Triphosphate
1
2016
89
0.030
 Why?
Primary Health Care
1
2007
1730
0.030
 Why?
Antifungal Agents
1
1997
150
0.030
 Why?
Half-Life
1
2016
152
0.030
 Why?
Child
7
2017
22600
0.030
 Why?
Lymphocyte Depletion
1
2016
133
0.030
 Why?
Tumor Necrosis Factor-alpha
1
2021
1207
0.030
 Why?
Eating
1
1999
388
0.030
 Why?
Nucleotides
1
2016
130
0.030
 Why?
Peru
1
2016
62
0.030
 Why?
Statistics, Nonparametric
2
2012
427
0.030
 Why?
Prognosis
2
2021
4312
0.030
 Why?
Spermatozoa
1
2016
107
0.030
 Why?
Forkhead Transcription Factors
1
2016
203
0.030
 Why?
Clinical Protocols
1
1997
282
0.030
 Why?
Heart Valve Prosthesis Implantation
1
1998
197
0.030
 Why?
Machine Learning
1
2021
587
0.030
 Why?
United States
6
2016
16018
0.030
 Why?
Human Activities
1
2015
21
0.030
 Why?
Randomized Controlled Trials as Topic
1
2022
1742
0.030
 Why?
Algorithms
2
2011
1844
0.030
 Why?
Intubation, Intratracheal
1
1998
323
0.030
 Why?
Piperazines
1
2018
378
0.030
 Why?
Receptors, CXCR4
2
2007
91
0.030
 Why?
Animals
4
2016
37948
0.030
 Why?
Drug Users
1
2015
42
0.030
 Why?
Blood
1
2015
106
0.030
 Why?
South Africa
1
2016
265
0.030
 Why?
Receptors, CCR7
1
2014
31
0.030
 Why?
Receptors, CXCR5
1
2014
27
0.030
 Why?
HEK293 Cells
1
2017
743
0.030
 Why?
Drug Administration Schedule
1
2016
779
0.030
 Why?
Cathelicidins
1
2014
41
0.030
 Why?
Adenosine Triphosphate
1
2016
501
0.030
 Why?
Polymerase Chain Reaction
2
2012
1047
0.030
 Why?
Mutation Rate
1
2014
30
0.030
 Why?
Gene Expression Regulation, Viral
1
2014
94
0.030
 Why?
Substance Abuse, Intravenous
1
2015
127
0.020
 Why?
Child, Preschool
4
2002
11790
0.020
 Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
32
0.020
 Why?
Aging, Premature
1
2013
16
0.020
 Why?
Body Fat Distribution
1
2013
45
0.020
 Why?
Registries
1
2022
2392
0.020
 Why?
Amino Acid Substitution
1
2014
303
0.020
 Why?
Kidney Failure, Chronic
1
1999
597
0.020
 Why?
Energy Metabolism
1
1999
927
0.020
 Why?
Infant
3
2002
10023
0.020
 Why?
Mothers
1
1999
765
0.020
 Why?
Bronchoalveolar Lavage Fluid
1
2015
630
0.020
 Why?
Infant, Newborn
2
1994
6399
0.020
 Why?
Muscles
1
2013
332
0.020
 Why?
Clone Cells
2
2002
263
0.020
 Why?
Cyclopropanes
1
2012
83
0.020
 Why?
Alkynes
1
2012
66
0.020
 Why?
Receptors, HIV
1
2011
23
0.020
 Why?
Confidence Intervals
1
2012
331
0.020
 Why?
Cardiac Surgical Procedures
1
1997
609
0.020
 Why?
Insulin-Like Growth Factor I
1
2013
317
0.020
 Why?
Bone and Bones
1
2013
317
0.020
 Why?
Epithelial Cells
1
2016
1106
0.020
 Why?
Geography
1
2011
203
0.020
 Why?
Disease Susceptibility
1
2012
342
0.020
 Why?
Chi-Square Distribution
2
2002
524
0.020
 Why?
Follow-Up Studies
2
2015
5414
0.020
 Why?
Interleukin-2
2
2003
438
0.020
 Why?
Pregnancy Complications, Infectious
1
1994
431
0.020
 Why?
North America
1
2011
312
0.020
 Why?
Depression
1
2019
1561
0.020
 Why?
Bone Density
1
2013
484
0.020
 Why?
Cell Proliferation
1
2016
2489
0.020
 Why?
Cost-Benefit Analysis
1
2012
638
0.020
 Why?
Body Mass Index
2
2013
2419
0.020
 Why?
Postoperative Complications
1
2001
2950
0.020
 Why?
Postoperative Hemorrhage
2
2000
104
0.020
 Why?
United States Department of Veterans Affairs
2
2004
771
0.020
 Why?
DNA, Viral
2
2000
357
0.020
 Why?
Respiratory Tract Diseases
2
2000
175
0.020
 Why?
Socioeconomic Factors
1
2012
1322
0.020
 Why?
Health Status
2
2004
834
0.020
 Why?
Gene Expression Regulation
1
2016
2591
0.020
 Why?
Magnetic Resonance Imaging
1
2000
3888
0.020
 Why?
Immunosuppressive Agents
1
2012
834
0.020
 Why?
DNA Primers
1
2008
507
0.020
 Why?
Lymphocyte Count
1
2007
164
0.020
 Why?
Personnel Turnover
1
2007
41
0.020
 Why?
Sweating
1
2007
42
0.020
 Why?
Risk Assessment
3
2004
3729
0.010
 Why?
Gender Identity
1
2007
126
0.010
 Why?
Hospital Mortality
2
2004
1033
0.010
 Why?
Health Care Surveys
1
2007
537
0.010
 Why?
Fever
1
2007
313
0.010
 Why?
Selection Bias
1
2005
38
0.010
 Why?
Obesity
1
1999
3070
0.010
 Why?
DNA
1
2012
1447
0.010
 Why?
Quality Indicators, Health Care
1
2007
335
0.010
 Why?
Base Sequence
1
2008
2177
0.010
 Why?
Acute Disease
1
2007
1029
0.010
 Why?
Cell Line
2
2001
2821
0.010
 Why?
HLA-A3 Antigen
1
2003
6
0.010
 Why?
HLA-B7 Antigen
1
2003
7
0.010
 Why?
Neoplasms
1
2019
2873
0.010
 Why?
HLA-A2 Antigen
1
2003
35
0.010
 Why?
Superantigens
1
2003
70
0.010
 Why?
Histocompatibility Testing
1
2003
122
0.010
 Why?
Cell Line, Transformed
1
2003
138
0.010
 Why?
Intraoperative Care
1
2004
63
0.010
 Why?
Double-Blind Method
1
2008
2033
0.010
 Why?
B7-2 Antigen
1
2002
27
0.010
 Why?
Virus Activation
1
2003
95
0.010
 Why?
Postoperative Period
1
2004
351
0.010
 Why?
Drug Evaluation, Preclinical
1
2003
195
0.010
 Why?
Chronic Disease
1
2009
1810
0.010
 Why?
Morbidity
1
2004
322
0.010
 Why?
Genes, T-Cell Receptor beta
1
2002
23
0.010
 Why?
Hospital-Physician Relations
1
2002
4
0.010
 Why?
Parainfluenza Virus 3, Human
1
2002
5
0.010
 Why?
Community Medicine
1
2002
7
0.010
 Why?
Rotavirus
1
2002
20
0.010
 Why?
CD40 Antigens
1
2002
89
0.010
 Why?
Attitude to Computers
1
2002
28
0.010
 Why?
Sick Role
1
2001
20
0.010
 Why?
HIV Core Protein p24
1
2001
32
0.010
 Why?
Immunity, Cellular
1
2003
272
0.010
 Why?
Streptococcus pyogenes
1
2002
41
0.010
 Why?
Pregnancy
1
1994
7122
0.010
 Why?
Enzyme-Linked Immunosorbent Assay
1
2003
835
0.010
 Why?
Health Services Research
1
2004
392
0.010
 Why?
Preoperative Care
1
2004
379
0.010
 Why?
Respiratory Syncytial Virus, Human
1
2002
81
0.010
 Why?
Nonlinear Dynamics
1
2001
96
0.010
 Why?
Phosphorus Radioisotopes
1
2000
25
0.010
 Why?
Elbow
1
2000
56
0.010
 Why?
Community-Acquired Infections
1
2002
175
0.010
 Why?
Hyperplasia
1
2000
177
0.010
 Why?
Knee
1
2000
71
0.010
 Why?
Ankle
1
2000
63
0.010
 Why?
Forecasting
1
2001
391
0.010
 Why?
Antigens, CD
1
2002
552
0.010
 Why?
Hemophilia B
1
2000
65
0.010
 Why?
Seasons
1
2002
556
0.010
 Why?
Synovial Membrane
1
2000
124
0.010
 Why?
Calorimetry, Indirect
1
1999
72
0.010
 Why?
Diet Records
1
1999
84
0.010
 Why?
Lymphocyte Culture Test, Mixed
1
1998
49
0.010
 Why?
Fathers
1
1999
51
0.010
 Why?
Cost Control
1
1998
37
0.010
 Why?
Amino Acid Sequence
1
2002
2136
0.010
 Why?
Mice, Transgenic
1
2003
2184
0.010
 Why?
Anthropometry
1
1999
197
0.010
 Why?
Activities of Daily Living
1
2001
441
0.010
 Why?
Erythrocyte Transfusion
1
2000
226
0.010
 Why?
Puberty
1
1999
135
0.010
 Why?
Radiography
1
2000
848
0.010
 Why?
Analysis of Variance
1
2000
1301
0.010
 Why?
Streptokinase
1
1996
9
0.010
 Why?
Phytohemagglutinins
1
1996
29
0.010
 Why?
Reproducibility of Results
1
2005
3414
0.010
 Why?
Tetanus Toxoid
1
1996
34
0.010
 Why?
Cell Division
1
1998
753
0.010
 Why?
Candida
1
1996
45
0.010
 Why?
Postoperative Care
1
1998
286
0.010
 Why?
Exercise Test
1
1999
626
0.010
 Why?
Antigens, Bacterial
1
1996
127
0.010
 Why?
Disease-Free Survival
1
1997
768
0.010
 Why?
Survival Rate
1
2000
2089
0.010
 Why?
Logistic Models
1
2000
2114
0.010
 Why?
Nuclear Proteins
1
1999
741
0.010
 Why?
Adipose Tissue
1
1999
643
0.010
 Why?
Patient Selection
1
1997
727
0.010
 Why?
Recombinant Proteins
1
1996
1363
0.010
 Why?
Databases, Factual
1
1999
1494
0.010
 Why?
Prevalence
1
1999
2839
0.010
 Why?
Mice
1
2003
18261
0.000
 Why?
MaWhinney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (515) concept(s)
_
Co-Authors Expand Description
See all (74) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)